New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
10:16 EDTGTN, CTSH, IMGN, AXASHigh option volume stocks: IMGN GTN RDA AXAS CTSH
News For IMGN;GTN;AXAS;CTSH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 19, 2014
13:16 EDTIMGNImmunoGen downgraded to Hold from Buy at Jefferies
Subscribe for More Information
12:27 EDTIMGNOn The Fly: Midday Wrap
Subscribe for More Information
09:28 EDTIMGNOn The Fly: Pre-market Movers
Subscribe for More Information
05:36 EDTIMGNImmunoGen reports Phase III MARIANNE study met non-inferiority endpoint
Subscribe for More Information
December 17, 2014
07:12 EDTAXASAbraxas Petroleum has strong wellhead level returns, says SunTrust
After conducting a well study in the Williston Basin, SunTrust says that Abraxas' wellhead-level returns appear to be the strongest in its coverage. The firm thinks the company's low debt levels leave it well-positioned to buy land at attractive prices. SunTrust reiterates a $5 price target and keeps a Buy rating on the stock. .
December 16, 2014
09:59 EDTAXASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:12 EDTCTSHCognizant called top pick in IT Services at Deutsche Bank
Subscribe for More Information
06:42 EDTAXASAbraxas Petroleum downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
06:20 EDTAXASAbraxas Petroleum to host conference call
Subscribe for More Information
December 15, 2014
18:30 EDTAXASOn The Fly: After Hours Movers
UP AFTER EARNINGS: VeriFone Systems (PAY), up 1.5%. ALSO HIGHER: Prothena (PRTA), up 10.7% after receiving FDA fast track designation for NEOD001... Boeing (BA), up 2.3% after increasing dividend by 25% and authorizing a $12B share repurchase plan... Yamana Gold (AUY), up 4.6% after reporting new discoveries at Chapada, El Penon. LOWER: Abraxas Petroleum (AXAS), down 2% after reporting fourth quarter volume guidance and fiscal 2015 production guidance.
18:07 EDTAXASAbraxas Petroleum CEO cites 'significant obstacles in Q4'
Subscribe for More Information
18:05 EDTAXASAbraxas Petroleum sees 2015 production 7,200-7,300 Boepd
Subscribe for More Information
17:59 EDTAXASAbraxas Petroleum sees Q4 volumes 6,700-6,800 Boepd
Subscribe for More Information
December 12, 2014
09:08 EDTCTSHHatch to look to push tech worker bill, Reuters reports
Subscribe for More Information
December 11, 2014
05:40 EDTCTSHCognizant resumed with an Overweight at Barclays
Subscribe for More Information
December 10, 2014
15:14 EDTIMGNImmunoGen volatility at high end of historic range
Subscribe for More Information
08:03 EDTCTSHCLSA to hold a summit
CLSA Innovation Summit is being held in New York on December 10-11.
December 8, 2014
11:57 EDTGTNGray Television management to meet with Sidoti
Meetings to be held in Montreal/Toronto on December 9 hosted by Sidoti.
07:40 EDTAXASMany E&P target prices lowered at SunTrust
Subscribe for More Information
December 7, 2014
12:53 EDTIMGNImmunoGen announces 'encouraging' IMGN529 clinical data
ImmunoGen announced the presentation of encouraging clinical findings with its IMGN529 experimental therapy for B-cell malignancies at the American Society of Hematology annual meeting. These include objective responses at doses that were generally well tolerated. ImmunoGenís IMGN529 is a potential new treatment for DLBCL and other non-Hodgkin lymphoma, NHL, subtypes. An ADC, it comprises an antibody that targets CD37, found on B-cell malignancies, with the potent cancer cell-killing agent, DM1, attached. The antibody serves to deliver the DM1 specifically to B cells to kill them and, based on preclinical research, also contributes anticancer activity. IMGN529 is currently in the dose-finding portion of a Phase I clinical trial, which assesses increasing doses of this experimental therapy in new groups of patients with relapsed/refractory NHL. Findings with the first doses evaluated were reported previously.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use